National Center for Advancing Translational Sciences; Notice of Meeting, 104193-104194 [2024-30325]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
Court of Federal Claims No: 24–1674V
89. Joseph Dusrajh, New York, New York,
Court of Federal Claims No: 24–1680V
90. Tiffany Blohm, De Pere, Wisconsin, Court
of Federal Claims No: 24–1681V
91. Michael T. Wagner, Boscobel, Wisconsin,
Court of Federal Claims No: 24–1682V
92. Eric Sedwick, Nashville, Tennessee,
Court of Federal Claims No: 24–1684V
93. Rachel Aviles, Boston, Massachusetts,
Court of Federal Claims No: 24–1685V
94. Lindsay Maldonado, Toppenish,
Washington, Court of Federal Claims No:
24–1686V
95. Timothy Nowling, Garden City Beach,
South Carolina, Court of Federal Claims
No: 24–1689V
96. Katherine Patterson, Raleigh, North
Carolina, Court of Federal Claims No:
24–1690V
97. Ianthie Jayakody, Federal Way,
Washington, Court of Federal Claims No:
24–1691V
98. Cathrine Mistele on behalf of J. M., Los
Angeles, California, Court of Federal
Claims No: 24–1692V
99. Alicia Ann Knight, Colorado Springs,
Colorado, Court of Federal Claims No:
24–1694V
100. Charles Jones, La Grande, Oregon, Court
of Federal Claims No: 24–1697V
101. Ashley Loncarich-Boeckman, Tulsa,
Oklahoma, Court of Federal Claims No:
24–1698V
102. Aida Acosta, Howell, Michigan, Court of
Federal Claims No: 24–1699V
103. Valerie Hoff, Atlanta, Georgia, Court of
Federal Claims No: 24–1700V
104. Sofia Gunawan, Phoenix, Arizona, Court
of Federal Claims No: 24–1701V
105. Felicia Markham, Redlands, Texas,
Court of Federal Claims No: 24–1702V
106. Makayla Wagner, St. Ansgar, Iowa,
Court of Federal Claims No: 24–1703V
107. Kimberly Rice, Chicago, Illinois, Court
of Federal Claims No: 24–1704V
108. Jennifer Camacho, Rock Hill, South
Carolina, Court of Federal Claims No:
24–1708V
109. Christopher Budge, White Bear Lake,
Minnesota, Court of Federal Claims No:
24–1709V
110. George Ward, Florence, Kentucky, Court
of Federal Claims No: 24–1711V
111. Heather J. Gardner, Port Huron,
Michigan, Court of Federal Claims No:
24–1712V
112. Maxfel Goodson, Ketchikan, Alaska,
Court of Federal Claims No: 24–1713V
113. Christine Leo, Goshen, New York, Court
of Federal Claims No: 24–1716V
114. Amie Marcott on behalf of A. M.,
Brownstown Township, Michigan, Court
of Federal Claims No: 24–1717V
115. Karen Kun, Chicago, Illinois, Court of
Federal Claims No: 24–1718V
116. Jennifer Plumley, Bozeman, Montana,
Court of Federal Claims No: 24–1721V
117. Leandra Logston and Cody Logston on
behalf of A. G. L., Boston, Massachusetts,
Court of Federal Claims No: 24–1724V
118. Kimberly Pino, Dresher, Pennsylvania,
Court of Federal Claims No: 24–1728V
119. Gregory Fridell, San Diego, California,
Court of Federal Claims No: 24–1730V
120. Virginia Fisher, Hornell, New York,
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
Court of Federal Claims No: 24–1732V
121. Michael Seck, Boston, Massachusetts,
Court of Federal Claims No: 24–1733V
122. Kaley Stockton, Los Angeles, California,
Court of Federal Claims No: 24–1736V
123. Robyn Boyd, Los Angeles, California,
Court of Federal Claims No: 24–1737V
124. Verdie Atienza, Chesapeake, Virginia,
Court of Federal Claims No: 24–1738V
125. Sabaha Sabi Zagwolsky, Orange,
California, Court of Federal Claims No:
24–1739V
126. Edward Cummings, Philadelphia,
Pennsylvania, Court of Federal Claims
No: 24–1742V
127. Daniel Diehl, Fort Knox, Kentucky,
Court of Federal Claims No: 24–1743V
128. Jennifer Credeur, Frisco, Texas, Court of
Federal Claims No: 24–1746V
129. Michael Dugas, Ventura, California,
Court of Federal Claims No: 24–1747V
130. Anife Tashi, Boston, Massachusetts,
Court of Federal Claims No: 24–1748V
131. John Morris, Los Angeles, California,
Court of Federal Claims No: 24–1751V
132. Adrianna Mckeage, Los Angeles,
California, Court of Federal Claims No:
24–1752V
133. Melissa Weber, New York, New York,
Court of Federal Claims No: 24–1753V
134. Kari Morey, Los Angeles, California,
Court of Federal Claims No: 24–1754V
135. Gary L. Tranmer, South Sioux City,
Nebraska, Court of Federal Claims No:
24–1755V
136. Tracey Kubis, Dresher, Pennsylvania,
Court of Federal Claims No: 24–1756V
137. Sonia Bittar, Quincy, Massachusetts,
Court of Federal Claims No: 24–1757V
138. Manuela Sympson, Ames, Iowa, Court of
Federal Claims No: 24–1758V
139. Bryan Payne, New Orleans, Louisiana,
Court of Federal Claims No: 24–1759V
140. Sara A. Morse, Hyde Park, New York,
Court of Federal Claims No: 24–1765V
141. Patricia Pervenanze, Minneapolis,
Minnesota, Court of Federal Claims No:
24–1768V
142. Elizabeth Christensen, Burlington,
Washington, Court of Federal Claims No:
24–1769V
143. Cathy A. Smeal, Ellsworth, Maine, Court
of Federal Claims No: 24–1772V
144. Ryan Stroup, Phoenix, Arizona, Court of
Federal Claims No: 24–1775V
145. Carol Bielski on behalf of Wayne Bielski,
Washington, District of Columbia, Court
of Federal Claims No: 24–1777V
146. Kimberly Cross, Richmond, Virginia,
Court of Federal Claims No: 24–1778V
147. Lily McNulty and Conor McNulty on
behalf of J.M., Phoenix, Arizona, Court of
Federal Claims No: 24–1779V
148. Mackenzie Larsen, Columbus, Ohio,
Court of Federal Claims No: 24–1782V
149. Clara Trigueros, Woodridge, Illinois,
Court of Federal Claims No: 24–1783V
150. John Lewis Walston, Austin, Texas,
Court of Federal Claims No: 24–1785V
151. Estella Fluaitt, Rockford, Illinois, Court
of Federal Claims No: 24–1786V
152. Gail L. Smith, Englewood, New Jersey,
Court of Federal Claims No: 24–1788V
153. Ryleigh Francis, Phoenix, Arizona,
Court of Federal Claims No: 24–1789V
154. Tyronda Roberson, Woodridge, Illinois,
PO 00000
Frm 00122
Fmt 4703
Sfmt 4703
104193
Court of Federal Claims No: 24–1790V
155. Thomas Judge, New York, New York,
Court of Federal Claims No: 24–1793
[FR Doc. 2024–30457 Filed 12–19–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Advancing Translational Sciences
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The Open
Session may be accessed by the public
from the NIH Videocast at the following
link: https://videocast.nih.gov.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: January 30–31, 2025.
Closed: January 30, 2025, 11:00 a.m. to
12:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Center for Advancing
Translational Sciences, National Institutes of
Health, NCI Shady Grove 1E32/1E34, 9609
Medical Center Drive, Rockville, MD 20850,
Virtual Meeting.
Open: January 30, 2025, 1:15 p.m. to 4:30
p.m.
Agenda: Report from the Center Director,
Clearance of Concept(s), Special Topic
presentation.
Address: National Center for Advancing
Translational Sciences, National Institutes of
Health, NCI Shady Grove 1E32/1E34, 9609
Medical Center Drive, Rockville, MD 20850,
Virtual Meeting.
Open: January 31, 2025, 1:00 p.m. to 5:00
p.m.
E:\FR\FM\20DEN1.SGM
20DEN1
104194
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
Agenda: Program Updates, Clearance of
Concepts.
Address: National Center for Advancing
Translational Sciences, National Institutes of
Health, NCI Shady Grove 1E32/1E34, 9609
Medical Center Drive, Rockville, MD 20850,
(Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing,
Ph.D.,Executive Secretary, National Center
for Advancing Translational Sciences, 9609
Medical Center Drive, Room 1E454,
Rockville, MD 20850, anna.ramseyewing@
nih.gov, (301) 435–0809.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice no later than 15 days after the
meeting at NCATSCouncilInput@
mail.nih.gov. The statement should include
the name, address, telephone number and
when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
ncats.nih.gov/advisory/council, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 16, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–30325 Filed 12–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Institute of Dental &
Craniofacial Research; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Dental
and Craniofacial Research Council.
The meeting will be held as a virtual
meeting and is partially open to the
public as indicated below. Individuals
who plan to view the virtual meeting
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
and need special assistance to view the
meeting, such as sign language
interpretation or other reasonable
accommodations, should notify Ms.
Karon Yarborough (karon.yarborough@
nih.gov) or use the Federal Relay, 1–
800–877–8339, in advance of the
meeting. The open session will be
videocast and can be accessed from the
NIH Videocasting website (https://
videocast.nih.gov/). Registration is not
required to access the videocast.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: January 22, 2025.
Open: 10:00 a.m. to 1:15 p.m.
Agenda: Report of the Director, NIDCR and
concept clearances.
Address: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Closed: 1:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate BSC
report to council.
Address: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Closed: 2:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute of Dental &
Craniofacial Research, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yasaman Shirazi, Ph.D.,
Branch Chief, National Institute of Dental &
Craniofacial Research, National Institutes of
Health, 31 Center Drive, Bethesda, MD
20892, 301–594–5593, Email:
yasaman.shirazi@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about-us/advisorycommittees/advisory-council, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
PO 00000
Frm 00123
Fmt 4703
Sfmt 4703
Dated: December 17, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30446 Filed 12–19–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Interagency Autism
Coordinating Committee.
The meeting will be virtually held
and is open to public viewing. The
connection information and how to
access the meeting will be available on
the IACC website https://iacc.hhs.gov/
meetings/iacc-meetings/2025/summaryof-advances/january14/. Advanced
registration is recommended.
Individuals wishing to participate
virtually that need special assistance or
other reasonable accommodations
should submit a request to the Contact
Person listed on this notice at least
seven (7) business days prior to the
meeting.
The purpose of the IACC meeting is
to discuss the committee’s nominations
of articles for the 2024 IACC Summary
of Advances in Autism Research report.
The final report will summarize the top
20 advances in autism biomedical and
services research, as selected by the
IACC.
Name of Committee: Interagency Autism
Coordinating Committee 2024 IACC
Summary of Advances in Autism Research.
Date: January 14, 2025.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To discuss the committee’s
nominations of articles for the 2024 IACC
Summary of Advances in Autism Research
report.
Address: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Cost: The meeting is free and open to the
public.
Registration: A registration web link will
be posted on the IACC website
(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended.
Contact Person: Ms. Rebecca Martin, Office
of National Autism Coordination, National
Institute of Mental Health, NIH, Phone: 301–
435–0886.
Email: IACCPublicInquiries@
mail.nih.gov.
Technical issues: If you experience
any technical problems with the zoom
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Pages 104193-104194]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30325]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Center for
Advancing Translational Sciences Advisory Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The Open Session may be
accessed by the public from the NIH Videocast at the following link:
https://videocast.nih.gov.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Advisory Council.
Date: January 30-31, 2025.
Closed: January 30, 2025, 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Address: National Center for Advancing Translational Sciences,
National Institutes of Health, NCI Shady Grove 1E32/1E34, 9609
Medical Center Drive, Rockville, MD 20850, Virtual Meeting.
Open: January 30, 2025, 1:15 p.m. to 4:30 p.m.
Agenda: Report from the Center Director, Clearance of
Concept(s), Special Topic presentation.
Address: National Center for Advancing Translational Sciences,
National Institutes of Health, NCI Shady Grove 1E32/1E34, 9609
Medical Center Drive, Rockville, MD 20850, Virtual Meeting.
Open: January 31, 2025, 1:00 p.m. to 5:00 p.m.
[[Page 104194]]
Agenda: Program Updates, Clearance of Concepts.
Address: National Center for Advancing Translational Sciences,
National Institutes of Health, NCI Shady Grove 1E32/1E34, 9609
Medical Center Drive, Rockville, MD 20850, (Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing, Ph.D.,Executive Secretary,
National Center for Advancing Translational Sciences, 9609 Medical
Center Drive, Room 1E454, Rockville, MD 20850,
[email protected], (301) 435-0809.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice no later than 15 days after the meeting at
[email protected]. The statement should include the
name, address, telephone number and when applicable, the business or
professional affiliation of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the Institute's/Center's home
page: https://ncats.nih.gov/advisory/council, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: December 16, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-30325 Filed 12-19-24; 8:45 am]
BILLING CODE 4140-01-P
